Neurobiology of Opioid Dependence: 2 - 2

Withdrawn before enrolling · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

Key facts

Study ID

NCT00000193

Run by

Yale University

People needed

0

Starts

1993-01-01

Expected to finish

1998-01-01

Last updated by the study team

2015-08-07

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

• VA Connecticut Healthcare System — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.